Related Experiment Video
Updated: Jan 13, 2026

14:04
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
15.8K
Neutrophil Plasticity and NETosis in Tumour Microenvironment: Tumour Evolution and Therapy Resistance
Mojdeh Soltani1, Sara Falahi1, Mohammad Abbaszadeh1
1Department of Immunology, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.
Journal of Immunology Research
|January 8, 2026
Summary
Neutrophil extracellular traps (NETs) are web-like DNA formations involved in immunity and disease. This review explores how NETosis in the tumor microenvironment (TME) impacts cancer progression, immune evasion, and therapy resistance.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Neutrophil extracellular traps (NETs) are DNA-based structures released by neutrophils.
- NET formation is implicated in innate immunity and autoimmune diseases.
- Emerging evidence links NETosis to cancer progression and metastasis.
Purpose of the Study:
- To review the role of NETosis in the tumor microenvironment (TME).
- To analyze the interplay between NETosis and TME components.
- To highlight implications for tumor progression, immune evasion, and therapy resistance.
Main Methods:
- Literature review of studies on NETs, NETosis, and the TME.
- Analysis of the mechanisms by which NETs influence the TME.
- Synthesis of current understanding of NETosis in cancer.
Main Results:
- NETs are present in primary and metastatic tumors, associated with tumor-associated neutrophils (TANs).
- NETs modulate immune surveillance within the TME.
- NETosis contributes to tumor progression, immune evasion, and resistance to cancer therapies.
Conclusions:
- NETosis is a significant factor in the tumor microenvironment.
- Targeting NETosis may offer novel therapeutic strategies for cancer.
- Further research is needed to fully elucidate the complex role of NETs in cancer.
Related Concept Videos
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

